Company has provided clarification regarding Demat requests received erroneously from shareholders of Supriya Pharmaceuticals Limited which is not related to Supriya Lifescience Limited.
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Supriya Lifescience has clarified to the exchanges that it is a completely separate entity from Supriya Pharmaceuticals Limited and has no affiliation or control over it. Some shareholders mistakenly sent dematerialisation requests for Supriya Pharmaceuticals shares to Supriya Lifescience, and the company wants to make clear it is not responsible for handling those shares. Shareholders of Supriya Pharmaceuticals are asked to approach that company directly. The company also confirmed that all its own shares are held in demat form and there is zero physical shareholding.
This is a routine administrative clarification to prevent confusion between two similarly named companies. It is not expected to have any material impact on Supriya Lifescience's stock price or shareholders, as it does not involve any regulatory action, financial event, or change in the company's business.